| Wiki Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Larry, Moe and Curley, Investment Brokers |
|
Wiki Articles - Larry, Moe and Curley, Investment Brokers
Larry, Moe and Curley were sitting in their
favorite restaurant just off Wall Street having
their usual 3 martini lunch and were disc According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ussing
the day’s events and their client portfolios. Larry:”I had 12 calls this morning from customers wanting to know why the mark ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in et was going down”. Moe: What did you tell them?” Curley: “Yeah, what”, taking another gulp of his libation. Larry: “You know, the us lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ual. This is
a normal correction and not to worry. I am
watching your account. The market always
comes back.” Moe: ”That’s the same here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe BS I tell them.” Curley: “ I have more than 300 accounts and I can’t watch them except my 5 big traders. Who cares about the others d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro anyway?
My company won’t let me tell them to sell when
their stock starts down and they believe the old
saw about ‘hang in there for ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc the long haul’. I
blew out of all my stocks last week. Thank
goodness. The market has dropped 300 points
since then. Moe: “It would b easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi better for the customers
if our company would let us tell them to use
stop loss orders." Larry and Moe, shouting in a single voice nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically : “Don’t say that or we’ll get fired”. They
both bonk him on the head spilling his drink.
“Nyuk. Nyuk.” Yes, it may sound funny, but t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ here is
more truth than fiction in that imaginary
conversation. Why don’t brokerage companies tell their customers to sell when the ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi market is
declining? There are two reasons. First any large brokerage does not want to get on the bad side of a company. That compa ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ny might have a public
offering later on and they will definitely not
be asked to sell any of the stock or bonds. This
is where the bi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod g money is on Wall Street.
The second reason is they don’t want the
customer to have cash in his account. He might
take it out. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin Brokers make money even if you do
not trade. It is not much, but it does keep the
pilot light lit. Brokers also discourage customer s tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen op loss
orders because it is more paper work for them
and then they do have to watch your account.
Unless your account is high 6-figur t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e or 7-figure
you are not on the radar screen. Mr. Broker (an
appropriate name for what he does with your
money) has an average of 300 ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust accounts and many
have 600 or 700. As new guys come into their
office they give them the little accounts. When a broker passes his se y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products curities license
he is given two manuals. One is SEC regulations
that must be followed and the second is how to
open accounts. There i . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de s no third manual on how
to protect customers’ money or trade. Brokerage
companies want their salesmen to follow the
company line and elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip push certain products. There is
no thought of customer protection. If your broker is Larry, Moe or Curley it is time to find a new one tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Customizing Your Stickers Made Easy
|